Profile data is unavailable for this security.
About the company
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
- Revenue in USD (TTM)492.05m
- Net income in USD197.92m
- Incorporated2008
- Employees581.00
- LocationInmode LtdTavor Building, Sha'ar Yokneam, Pob 533YOKNEAM 2069200IsraelISR
- Phone+972 49097470
- Websitehttps://inmodemd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avanos Medical Inc | 673.30m | -9.90m | 824.74m | 3.77k | -- | 0.6667 | 22.78 | 1.22 | -0.2092 | -1.32 | 14.43 | 26.77 | 0.387 | 1.66 | 4.73 | 178,546.80 | -0.5691 | -0.6527 | -0.6473 | -0.7338 | 56.39 | 54.45 | -1.47 | -1.60 | 1.38 | 4.27 | 0.1196 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Artivion Inc | 354.00m | -30.57m | 845.46m | 1.50k | -- | 2.96 | -- | 2.39 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| MiMedx Group Inc | 321.48m | 55.80m | 917.76m | 895.00 | 24.20 | 6.40 | 14.31 | 2.85 | 0.2581 | 0.2192 | 2.19 | 0.976 | 1.57 | 3.19 | 6.63 | 359,192.20 | 32.86 | -4.14 | 42.03 | -5.90 | 83.01 | 83.61 | 20.98 | -2.70 | 3.11 | 7.11 | 0.256 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Perspective Therapeutics Inc | 8.17m | -25.10m | 939.51m | 88.00 | -- | 4.55 | -- | 114.98 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
| AtriCure Inc | 399.25m | -30.44m | 1.09bn | 1.20k | -- | 2.31 | -- | 2.74 | -0.6569 | -0.6569 | 8.62 | 9.81 | 0.6658 | 1.74 | 8.39 | 332,704.20 | -5.08 | -3.72 | -5.71 | -4.10 | 75.23 | 74.36 | -7.62 | -7.64 | 2.66 | -8.52 | 0.1301 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| Adapthealth Corp | 3.20bn | -678.90m | 1.27bn | 10.70k | -- | 0.8712 | -- | 0.3979 | -5.06 | -5.06 | 23.77 | 11.00 | 0.6579 | 21.79 | 8.56 | 299,082.00 | -13.87 | -4.34 | -15.48 | -4.89 | 17.82 | 18.28 | -21.09 | -6.47 | 0.997 | 1.83 | 0.5978 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Establishment Labs Holdings Inc | 165.15m | -78.50m | 1.33bn | 908.00 | -- | 68.84 | -- | 8.07 | -3.05 | -3.05 | 6.45 | 0.7051 | 0.6886 | 1.00 | 4.01 | 181,884.40 | -32.73 | -33.22 | -40.93 | -41.12 | 64.78 | 64.73 | -47.53 | -43.19 | 1.67 | -13.08 | 0.9112 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| LeMaitre Vascular Inc | 193.48m | 30.11m | 1.41bn | 614.00 | 46.92 | 4.72 | 35.69 | 7.31 | 1.34 | 1.34 | 8.63 | 13.34 | 0.5888 | 1.23 | 8.22 | 315,120.50 | 9.16 | 9.02 | 10.00 | 9.93 | 65.66 | 65.83 | 15.56 | 15.45 | 4.57 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Inmode Ltd | 492.05m | 197.92m | 1.44bn | 581.00 | 7.38 | 1.82 | 7.25 | 2.93 | 2.30 | 2.30 | 5.73 | 9.38 | 0.6527 | 1.90 | 14.19 | 846,898.40 | 26.25 | 31.32 | 29.07 | 35.64 | 83.60 | 84.46 | 40.22 | 39.65 | 12.48 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| Warby Parker Inc | 669.77m | -63.20m | 1.51bn | 2.14k | -- | 4.99 | -- | 2.25 | -0.5376 | -0.5376 | 5.71 | 2.55 | 1.17 | 4.65 | 416.78 | 312,974.30 | -11.00 | -- | -14.16 | -- | 54.53 | 57.49 | -9.44 | -14.53 | 1.86 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| UFP Technologies Inc | 400.07m | 44.92m | 1.60bn | 3.09k | 35.93 | 5.60 | 28.44 | 4.00 | 5.84 | 5.84 | 51.97 | 37.45 | 1.02 | 4.65 | 6.69 | 129,347.20 | 11.48 | 9.69 | 13.45 | 10.95 | 28.05 | 26.33 | 11.23 | 10.14 | 1.28 | 15.86 | 0.101 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Alphatec Holdings Inc | 482.26m | -186.64m | 1.69bn | 839.00 | -- | 21.82 | -- | 3.50 | -1.54 | -1.54 | 3.98 | 0.7305 | 0.7273 | 1.44 | 7.06 | 574,805.80 | -28.15 | -30.97 | -36.25 | -39.47 | 64.32 | 66.02 | -38.70 | -46.22 | 1.99 | -5.40 | 0.8345 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Owens & Minor, Inc. | 10.33bn | -41.30m | 1.85bn | 13.70k | -- | 2.00 | 7.51 | 0.1788 | -0.5479 | -0.5479 | 136.31 | 12.07 | 1.97 | 6.72 | 15.18 | 754,304.20 | -0.7882 | 1.32 | -1.18 | 2.07 | 20.56 | 16.48 | -0.3997 | 0.5614 | 0.5244 | 2.04 | 0.6944 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Conmed Corp | 1.26bn | 82.35m | 1.91bn | 4.00k | 23.70 | -- | 12.35 | 1.51 | 2.61 | 2.61 | 39.97 | -- | -- | -- | -- | 315,387.00 | -- | 0.8972 | -- | 1.02 | 54.94 | 54.95 | 6.53 | 1.65 | -- | 3.76 | -- | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
Data as of Apr 26 2024. Currency figures normalised to Inmode Ltd's reporting currency: US Dollar USD
23.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 5.50m | 6.53% |
| Meitav Mutual Funds Ltd.as of 31 Dec 2023 | 1.94m | 2.30% |
| LSV Asset Managementas of 31 Dec 2023 | 1.94m | 2.30% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 1.94m | 2.30% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.84m | 2.18% |
| Acadian Asset Management LLCas of 31 Dec 2023 | 1.58m | 1.88% |
| Boston Trust Walden, Inc.as of 31 Dec 2023 | 1.46m | 1.73% |
| DDD Partners LLCas of 31 Dec 2023 | 1.23m | 1.46% |
| Menora Mivtachim Insurance Ltd.as of 31 Dec 2023 | 1.17m | 1.39% |
| American Century Investment Management, Inc.as of 31 Dec 2023 | 974.81k | 1.16% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
